Prostate volume and adverse prostate cancer features: Fact not artifact

被引:74
作者
Briyanti, Alberto [1 ,2 ]
Chun, Felix K. -H. [1 ,3 ]
Suardi, Nazareno [1 ,2 ]
Gallina, Andrea [1 ,2 ]
Walz, Jochen [1 ,3 ]
Graefen, Markus [4 ]
Shariat, Shahrokh [1 ]
Ebersdobler, Andreas [5 ]
Rigatti, Patrizio
Perrotte, Paul [1 ]
Saad, Fred
Montorsi, Francesco [2 ]
Huland, Hartwig [3 ,4 ]
Karakiewicz, Pierre I. [1 ]
机构
[1] Univ Montreal, Ctr Hlth, Canc Prognost & Hlth Outcomes Unit, Montreal, PQ H2X 3J4, Canada
[2] Vita State Univ, Dept Urol, Milan, Italy
[3] Univ Hamburg, Dept Urol, Hamburg, Germany
[4] Univ Hamburg, Prostate Canc Ctr, Martini Clin, Hamburg, Germany
[5] Univ Hamburg, Dept Pathol, Hamburg, Germany
关键词
prostate cancer; prostate volume; high grade prostate cancer;
D O I
10.1016/j.ejca.2007.09.022
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: A recent prostate cancer finasteride chemoprevention trial showed a higher rate of sextant biopsy-detected high grade prostate cancer (HGPCa) in finasteride exposed men, whose prostates were significantly smaller than those of controls. We investigated the association between prostate size and prostate cancer grade and stage in a large (n = 3412) single center radical prostatectomy cohort, which was unexposed to any form of hormonal manipulation. Methods: Logistic regression models were used. Results: Small prostates were associated with higher rate of HGPCa at biopsy and at radical prostatectomy (both p < 0.001), with higher rate of extracapsular extension (p < 0.001), seminal vesicle invasion (p < 0.001) and with tumor volume > 3.4cc, after accounting for age, PSA, clinical stage and year of surgery. Conclusions: Our findings demonstrate that prostate cancers located in small glands are fundamentally more aggressive than those located within larger glands. in consequence, prostate cancer detection and treatment strategies should account for prostate volume. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2669 / 2677
页数:9
相关论文
共 24 条
[1]   The effects of 5α-reductase inhibitors on the natural history, detection and grading of prostate cancer:: Current state of knowledge [J].
Andriole, G ;
Bostwick, D ;
Civantos, F ;
Epstein, J ;
Lucia, MS ;
McConnell, J ;
Roehrborn, CG .
JOURNAL OF UROLOGY, 2005, 174 (06) :2098-2104
[2]  
Bostwick David G, 2004, Clin Prostate Cancer, V2, P228, DOI 10.3816/CGC.2004.n.004
[3]   Prostate cancer detection: Relationship to prostate size [J].
Chen, ME ;
Troncoso, P ;
Johnston, D ;
Tang, K ;
Babaian, RJ .
UROLOGY, 1999, 53 (04) :764-768
[4]   Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: A search database study [J].
Freedland, SJ ;
Isaacs, WB ;
Platz, EA ;
Terris, MK ;
Aronson, WJ ;
Amling, CL ;
Presti, JC ;
Kane, CJ .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (30) :7546-7554
[5]   IMMUNOHISTOCHEMICAL DETECTION OF P53 PROTEIN IN HUMAN PROSTATIC-CANCER [J].
HENKE, RP ;
KRUGER, E ;
AYHAN, N ;
HUBNER, D ;
HAMMERER, P ;
HULAND, H .
JOURNAL OF UROLOGY, 1994, 152 (04) :1297-1301
[6]  
HIGGINS B, 2004, J UROLOGY, V171, pS8
[7]  
Higgins Betsy, 2004, Journal of Urology, V171, pS15, DOI 10.1097/01.ju.0000107440.15626.11
[8]   Estrogen receptor β in prostate cancer [J].
Imamov, O ;
Lopatkin, NA ;
Gustafsson, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (26) :2773-2774
[9]   Outcome of sextant biopsy according to gland volume [J].
Karakiewicz, PI ;
Bazinet, M ;
Aprikian, AG ;
Trudel, C ;
Aronson, S ;
Nachabe, M ;
Peloquint, F ;
Dessureault, J ;
Goyal, MS ;
Begin, LR ;
Elhilali, MM .
UROLOGY, 1997, 49 (01) :55-59
[10]   Evidence for a biopsy derived grade artifact among larger prostate glands [J].
Kulkarni, GS ;
Al-Azab, R ;
Lockwood, G ;
Toi, A ;
Evans, A ;
Trachtenberg, J ;
Jewett, MAS ;
Finelli, A ;
Fleshner, NE .
JOURNAL OF UROLOGY, 2006, 175 (02) :505-509